Novavax Inc at TD Cowen Health Care Conference Transcript
Joining us at TD Cowen Healthcare Conference. My name is Georgi Yordanov, one of the biopharma analysts. And I'd like to welcome John Trizzino, Chief Commercial Officer at Novavax.
Questions & Answers
So maybe, John, kind of like taking a step back, 2022 obviously shaped up to be quite of a turbulent year, a lot of evolving pieces, some high expectations from your team in terms of participating in the pandemic market. But 2023 is shaping to be quite different. We're entering the endemic market. So maybe can you just talk about the key priorities for Novavax as we enter 2023 and beyond?
Yes. So first of all, thanks, Georgi, for having timing me here. I'm happy to talk about our successes and what the future looks like. And so while '22 was challenging in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
